Diabetic ketoacidosis

Diabetic ketoacidosis
Name	Diabetic ketoacidosis
Field	Endocrinology

Diabetic ketoacidosis is an acute, life‑threatening metabolic emergency characterized by hyperglycemia, metabolic acidosis, and ketonemia. It commonly arises in people with insulin deficiency and is managed in hospital settings by multidisciplinary teams from endocrinology, intensive care, and emergency medicine. Presentation, management, and outcomes intersect with care pathways in institutions such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and public health systems like the National Health Service.

Signs and symptoms

Patients present with polyuria, polydipsia, and dehydration along with abdominal pain, nausea, vomiting, and altered mental status; these features prompt evaluation in emergency departments such as Beth Israel Deaconess Medical Center and Mount Sinai Hospital. Physical findings include tachycardia, hypotension, Kussmaul respirations, and fruity breath odor, leading clinicians from American Diabetes Association and International Diabetes Federation to issue management guidelines. In severe cases, confusion, stupor, or coma necessitates intensive care at centers like Toronto General Hospital and Royal Melbourne Hospital.

Causes and risk factors

Typical precipitants include infection, inadequate insulin therapy, and myocardial infarction, with triggers documented in studies from World Health Organization, Centers for Disease Control and Prevention, and European Centre for Disease Prevention and Control. Other risk factors are new‑onset autoimmune beta‑cell failure, trauma, pancreatitis, and use of medications such as sodium‑glucose cotransporter‑2 inhibitors highlighted by regulatory agencies like the U.S. Food and Drug Administration and European Medicines Agency. Social determinants affecting access to insulin involve advocacy groups such as American Diabetes Association and Diabetes UK.

Pathophysiology

Pathophysiology centers on absolute or relative insulin deficiency and counterregulatory hormone excess (glucagon, catecholamines, cortisol, growth hormone), mechanisms described in classical texts from Harvard Medical School, Oxford University Press, and reviews in journals affiliated with The Lancet and New England Journal of Medicine. Insulin deficiency increases lipolysis and hepatic ketogenesis, raising acetoacetate and beta‑hydroxybutyrate levels; this biochemical cascade has been investigated in experimental work at institutions including Stanford University, Yale School of Medicine, and Karolinska Institutet. Electrolyte shifts (notably potassium) and acid‑base disturbances are central considerations in protocols used by European Society of Intensive Care Medicine and Society of Critical Care Medicine.

Diagnosis

Diagnosis relies on hyperglycemia, metabolic acidosis (low arterial pH, low bicarbonate), and elevated serum or urine ketones, using laboratory services from centers like Quest Diagnostics and Molecular Diagnostics Laboratory at University of Washington. Diagnostic criteria are included in position statements from American Diabetes Association, International Society for Pediatric and Adolescent Diabetes, and national guidelines from NICE and Australian Diabetes Society. Point‑of‑care testing, arterial blood gas analysis, and electrolyte panels guide recognition in emergency departments at hospitals such as Royal Infirmary of Edinburgh and Groote Schuur Hospital.

Treatment

Treatment priorities are fluid resuscitation, insulin therapy, correction of electrolyte imbalances, and addressing precipitating causes; these steps are reflected in protocols from American Association of Clinical Endocrinologists, European Association for the Study of Diabetes, and intensive care units at Johns Hopkins Hospital. Intravenous isotonic crystalloids, regular insulin infusions, potassium monitoring, and transition to subcutaneous insulin are standard, with adjunctive measures considered in specialized centers like Cleveland Clinic and Mayo Clinic. When complicated by cerebral edema, teams experienced in pediatric critical care at Boston Children’s Hospital and Great Ormond Street Hospital apply neurosurgical and neurocritical care pathways.

Complications and prognosis

Acute complications include electrolyte disturbances, hypoglycemia during treatment, thromboembolism, acute kidney injury, and cerebral edema—risks described in cohort studies from Johns Hopkins Bloomberg School of Public Health, Imperial College London, and Karolinska University Hospital. Mortality has declined in high‑resource settings with organized care in tertiary centers like Massachusetts General Hospital, though remains higher where resources are limited, prompting global health initiatives by World Health Organization and United Nations Children’s Fund. Long‑term prognosis depends on recurrence risk, glycemic control, and comorbid conditions managed by primary and specialty clinics associated with University of California San Francisco Health.

Epidemiology

Incidence varies by region and healthcare access, with population studies from United States, United Kingdom, Sweden, Australia, and Canada showing differing rates among type 1 and type 2 diabetes cohorts. Surveillance data from Centers for Disease Control and Prevention, Public Health England, Statens Serum Institut, and national registries indicate higher incidence among adolescents, young adults, and socioeconomically disadvantaged groups; international research collaborations at International Diabetes Federation quantify global burden. Trends reflect impacts of insulin availability, outpatient care models at institutions such as Kaiser Permanente, and public health policies enacted by bodies like the World Bank.

Category:Endocrine emergencies